Table 5.
Univariate analysis of CTCL-γδ
| Clinicopathological characteristics | N | 5-year OS | P |
|---|---|---|---|
| Clinical profile | |||
| Age | |||
| <60 | 10 | 64.0 | 0.036 |
| ≧60 | 7 | 48.0 | |
| Gender | |||
| Male | 10 | 40.0 | 0.179 |
| Female | 7 | 85.7 | |
| Lesion | |||
| Single | 3 | 66.7 | 0.962 |
| Multiple or general | 14 | 53.6 | |
| Tumor size | |||
| <5 | 5 | 75.0 | 0.525 |
| ≧5 | 5 | 53.3 | |
| Lymph node involvement | |||
| + | 11 | 44.4 | 0.301 |
| − | 6 | 57.3 | |
| Visceral involvement | |||
| + | 3 | 0 | 0.016 |
| − | 14 | 67.3 | |
| LDH above normal | |||
| + | 10 | 48.0 | 0.824 |
| − | 5 | 50.0 | |
| B symptoms | |||
| + | 5 | 40.0 | 0.681 |
| − | 12 | 54.7 | |
| Clinical stage | |||
| I | 4 | 75.0 | 0.546 |
| II | 3 | 65.7 | |
| III | 1 | ND | |
| IV | 8 | 37.5 | |
| TNM | |||
| T1 | 4 | 50.0 | 0.534 |
| T2 | 3 | 0 | |
| T3 | 8 | 50.0 | |
| Histological profile | |||
| Location | |||
| Dermal | 2 | 50.0 | 0.534 |
| Dermal to subcutaneous | 14 | 56.8 | |
| Ulceration | |||
| + | 4 | 0 | 0.166 |
| − | 13 | 67.3 | |
| Epidermotropism | |||
| + | 3 | 66.7 | 0.971 |
| − | 13 | 65.3 | |
| Tumor necrosis | |||
| + | 5 | 26.7 | 0.618 |
| − | 11 | 70.1 | |
| Angioinvasion | |||
| + | 4 | 25.0 | 0.318 |
| − | 12 | 66.8 | |
| Cell size | |||
| Small to medium | 4 | 0 | 0.041 |
| Large | 13 | 65.3 | |
| SPTCL feature | |||
| + | 6 | 80.0 | 0.065 |
| − | 11 | 42.4 | |
CTCL, cutaneous T-cell lymphoma; ND, no data; OS, overall survival; SPTCL, subcutaneous panniculitis-like T-cell lymphoma.